ScreenerHero
AEDAedifica SA
EBR · BE · Real Estate · REIT - Healthcare Facilities · aedifica.eu
67.60EUR-0.59%Mkt Cap: 6.17B $P/E: 5.92

Aedifica NV/SA is a Belgian public regulated real estate company specializing in European healthcare real estate, particularly properties for elderly care. Aedifica has built a real estate portfolio worth approximately 1…

Industry Peers

REIT - Healthcare Facilities
Screen all
WELL
Welltower Inc.
$169.86BUSDP/E 105.2
VTR
Ventas, Inc.
$47.11BUSDP/E 167.0
OHI
Omega Healthcare Investors, Inc.
$14.80BUSDP/E 16.7
DOC
Healthpeak Properties, Inc.
$14.72BUSDP/E 59.3
CTRE
CareTrust REIT, Inc.
$9.41BUSDP/E 24.9
HR
Healthcare Realty Trust Incorporated
$6.78BUSD
SBRA
Sabra Health Care REIT, Inc.
$5.25BUSDP/E 79.0
CSH-UN
Chartwell Retirement Residences
$5.06BUSDP/E 1054.0
NHI
National Health Investors, Inc.
$3.64BUSDP/E 21.4
PHP
Primary Health Properties PLC
$3.17BUSDP/E 15.9
MPT
Medical Properties Trust Inc. common stock
$2.48BUSD
LTC
LTC Properties, Inc.
$2.17BUSDP/E 14.4
DHC
Diversified Healthcare Trust
$1.96BUSD
SILA
Sila Realty Trust Inc. Common Stock
$1.68BUSDP/E 44.6
STRW
Strawberry Fields REIT Inc. Common Stock
$769.23MUSDP/E 20.9
NHP
National Healthcare Properties Inc. Class A Common Stock
$747.36MUSD
CPINV
Care Property Invest
$563.33MUSDP/E 8.1
UHT
Universal Health Realty Income Trust
$571.24MUSDP/E 29.6
XRN
Chiron Real Estate Inc. Common Stock
$533.88MUSDP/E 9.9
CHCT
Community Healthcare Trust Incorporated
$422.58MUSDP/E 22.1

Key Statistics

Company
Market Cap6.17B $
Enterprise Value12.49B $
Revenue (TTM)425.31M $
Gross Profit378.87M $
Net Income (TTM)265.69M $
Revenue/Share8.550 USD
Last Price67.60 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees127
CountryBE
SectorReal Estate
IndustryREIT - Healthcare Facilities
ISINBE0003851681
Valuation
P/E (Trailing)5.92
P/E (Forward)12.35
PEG—
EV/EBITDA34.90
EV/Revenue29.38
P/S14.51
P/B0.85
EPS (TTM)11.49
EPS (Forward)5.51
52W Range
59.5039% of range80.05
52W High80.05 EUR
52W Low59.50 EUR
Profitability
Gross Margin94.16%
Oper. Margin80.17%
EBITDA Margin84.19%
Profit Margin66.03%
ROE6.67%
ROA3.77%
Growth
Revenue Growth23.40%
Earnings Growth481.10%
Cash Flow & Leverage
Operating CF345.48M $
CapEx (TTM)105.93M $
FCF Margin—
FCF Yield—
Net Debt5.41B $
Net Debt/EBITDA15.12
Balance Sheet
Debt/Equity0.70
Current Ratio0.11
Quick Ratio0.07
Book Value/Sh79.79 EUR
Cash/Share0.5390 EUR
Dividends
Fwd Div Rate4.000 EUR
Trail. Div Rate4.000 EUR
Div. Yield5.96%
5Y Avg Yield4.66%
Payout Ratio33.94%
Ex-Div DateMay 14, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)83.20 EUR
Upside (mean)+23.1%
Target Range70.00 EUR – 94.00 EUR
€70.00+23.1% to mean€94.00
# Analysts10
Ownership
Shares Out.83.47M
Float83.42M
Insiders0.06%
Institutions36.43%
Technical
SMA 5069.52 (-2.8%)
SMA 20070.61 (-4.3%)
Beta0.96
S&P 52W Chg18.16%
Avg Vol (30d)97.00K
Avg Vol (10d)99.43K
Technical Indicators
RSI (14)42.3
MACD-0.6848
MACD Signal-0.4468
MACD Hist.-0.2380
BB Upper72.18 EUR
BB Middle69.27 EUR
BB Lower66.35 EUR
BB Width8.43%
ATR (14)0.9427 EUR
Vol Ratio (20d)0.79x